Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Biological Science Disciplines | 3 | 2023 | 57 | 2.370 |
Why?
|
HIV Infections | 31 | 2023 | 17165 | 1.460 |
Why?
|
Aging | 15 | 2024 | 8651 | 1.290 |
Why?
|
HIV-1 | 21 | 2022 | 6849 | 0.930 |
Why?
|
Geriatrics | 2 | 2023 | 387 | 0.770 |
Why?
|
Journal Impact Factor | 1 | 2023 | 156 | 0.770 |
Why?
|
Plants | 1 | 2022 | 317 | 0.740 |
Why?
|
RNA Editing | 3 | 2010 | 151 | 0.710 |
Why?
|
Air Pollutants, Occupational | 1 | 2022 | 407 | 0.700 |
Why?
|
Muscle, Skeletal | 9 | 2023 | 4925 | 0.680 |
Why?
|
Sarcopenia | 2 | 2023 | 372 | 0.670 |
Why?
|
Ecosystem | 1 | 2022 | 485 | 0.610 |
Why?
|
Testosterone | 8 | 2022 | 2470 | 0.590 |
Why?
|
Longevity | 6 | 2023 | 1050 | 0.590 |
Why?
|
Asymptomatic Infections | 1 | 2018 | 131 | 0.580 |
Why?
|
Neurosciences | 1 | 2022 | 353 | 0.570 |
Why?
|
Inflammation | 6 | 2023 | 10756 | 0.560 |
Why?
|
Antiretroviral Therapy, Highly Active | 4 | 2022 | 1894 | 0.540 |
Why?
|
Publishing | 1 | 2023 | 836 | 0.510 |
Why?
|
Cytomegalovirus Infections | 1 | 2022 | 831 | 0.500 |
Why?
|
Continuity of Patient Care | 1 | 2022 | 1066 | 0.480 |
Why?
|
Neisseria gonorrhoeae | 2 | 2006 | 238 | 0.430 |
Why?
|
Antigens, Ly | 2 | 2010 | 292 | 0.420 |
Why?
|
Occupational Exposure | 1 | 2022 | 1809 | 0.400 |
Why?
|
Osteoporosis | 1 | 2022 | 1600 | 0.400 |
Why?
|
Gonorrhea | 2 | 2006 | 343 | 0.390 |
Why?
|
Hepatitis C | 1 | 2022 | 1579 | 0.390 |
Why?
|
Mitochondria | 1 | 2024 | 3600 | 0.370 |
Why?
|
Circadian Rhythm | 1 | 2022 | 2571 | 0.360 |
Why?
|
Virus Activation | 1 | 2012 | 319 | 0.360 |
Why?
|
Azepines | 1 | 2012 | 330 | 0.350 |
Why?
|
Biology | 2 | 2022 | 290 | 0.340 |
Why?
|
Fractures, Bone | 1 | 2022 | 2041 | 0.330 |
Why?
|
Virus Latency | 1 | 2012 | 362 | 0.330 |
Why?
|
Leukocytes, Mononuclear | 3 | 2023 | 1827 | 0.330 |
Why?
|
Physical Fitness | 1 | 2013 | 732 | 0.330 |
Why?
|
Myoblasts | 1 | 2010 | 232 | 0.320 |
Why?
|
Androgens | 3 | 2017 | 1291 | 0.320 |
Why?
|
Adenosine Deaminase | 2 | 2010 | 251 | 0.320 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2023 | 3334 | 0.310 |
Why?
|
Head and Neck Neoplasms | 1 | 2022 | 2882 | 0.310 |
Why?
|
Anti-HIV Agents | 4 | 2022 | 4491 | 0.300 |
Why?
|
Infectious Disease Transmission, Vertical | 3 | 2006 | 1348 | 0.300 |
Why?
|
Pain | 1 | 2023 | 5066 | 0.290 |
Why?
|
Exercise | 4 | 2020 | 5787 | 0.290 |
Why?
|
HIV Long Terminal Repeat | 6 | 2002 | 85 | 0.290 |
Why?
|
NF-kappa B | 6 | 2002 | 2488 | 0.290 |
Why?
|
HIV Wasting Syndrome | 1 | 2007 | 97 | 0.280 |
Why?
|
Triazoles | 1 | 2012 | 904 | 0.280 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2012 | 1347 | 0.270 |
Why?
|
Osteoblasts | 1 | 2012 | 1142 | 0.270 |
Why?
|
Small Molecule Libraries | 1 | 2012 | 734 | 0.270 |
Why?
|
Proviruses | 4 | 2013 | 313 | 0.270 |
Why?
|
High-Throughput Screening Assays | 1 | 2012 | 944 | 0.260 |
Why?
|
Energy Metabolism | 4 | 2022 | 2869 | 0.260 |
Why?
|
Regeneration | 2 | 2010 | 1506 | 0.240 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2013 | 4357 | 0.240 |
Why?
|
Humans | 61 | 2024 | 760621 | 0.240 |
Why?
|
Health Services Accessibility | 1 | 2022 | 5397 | 0.230 |
Why?
|
Biomedical Research | 1 | 2019 | 3426 | 0.230 |
Why?
|
Anti-Retroviral Agents | 1 | 2013 | 1779 | 0.230 |
Why?
|
Interleukin-6 | 1 | 2013 | 3215 | 0.220 |
Why?
|
HIV | 4 | 2023 | 1579 | 0.210 |
Why?
|
Stress, Physiological | 1 | 2010 | 1398 | 0.210 |
Why?
|
Enhancer Elements, Genetic | 2 | 2000 | 1356 | 0.200 |
Why?
|
Viral Load | 6 | 2006 | 3322 | 0.200 |
Why?
|
Viral Tropism | 2 | 2013 | 102 | 0.190 |
Why?
|
RNA Interference | 1 | 2010 | 2846 | 0.190 |
Why?
|
Th1 Cells | 1 | 2006 | 1032 | 0.180 |
Why?
|
Protein Modification, Translational | 1 | 2020 | 21 | 0.180 |
Why?
|
Th2 Cells | 1 | 2006 | 1047 | 0.180 |
Why?
|
Terminal Repeat Sequences | 2 | 2000 | 70 | 0.180 |
Why?
|
Disease Management | 2 | 2022 | 2514 | 0.170 |
Why?
|
TATA Box | 2 | 2001 | 127 | 0.170 |
Why?
|
Botswana | 6 | 2007 | 1040 | 0.170 |
Why?
|
Genes, Helminth | 2 | 2010 | 146 | 0.170 |
Why?
|
Immunity, Innate | 2 | 2010 | 3047 | 0.160 |
Why?
|
Immunosuppressive Agents | 1 | 2012 | 4166 | 0.160 |
Why?
|
Gene Expression Regulation, Viral | 3 | 2012 | 438 | 0.160 |
Why?
|
RNA, Messenger | 2 | 2012 | 12766 | 0.160 |
Why?
|
Neoplasms | 2 | 2022 | 22072 | 0.150 |
Why?
|
Membrane Proteins | 3 | 2010 | 7850 | 0.150 |
Why?
|
Viremia | 4 | 2018 | 707 | 0.150 |
Why?
|
Aged | 15 | 2023 | 169152 | 0.150 |
Why?
|
MicroRNAs | 2 | 2011 | 3790 | 0.150 |
Why?
|
NAD | 1 | 2022 | 609 | 0.150 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2024 | 806 | 0.150 |
Why?
|
Transforming Growth Factor beta1 | 2 | 2012 | 608 | 0.150 |
Why?
|
Congresses as Topic | 2 | 2019 | 805 | 0.150 |
Why?
|
Middle Aged | 19 | 2023 | 220352 | 0.150 |
Why?
|
Body Composition | 3 | 2020 | 2419 | 0.150 |
Why?
|
Mental Fatigue | 1 | 2017 | 22 | 0.140 |
Why?
|
Cell Line | 6 | 2012 | 15620 | 0.140 |
Why?
|
Muscle Proteins | 1 | 2022 | 1152 | 0.140 |
Why?
|
Gene Expression Profiling | 3 | 2008 | 9411 | 0.140 |
Why?
|
Proteome | 2 | 2022 | 1855 | 0.140 |
Why?
|
Iron-Binding Proteins | 1 | 2016 | 79 | 0.140 |
Why?
|
Activin Receptors, Type II | 1 | 2017 | 124 | 0.130 |
Why?
|
Comorbidity | 4 | 2022 | 10551 | 0.130 |
Why?
|
Gene Products, tat | 3 | 2002 | 111 | 0.130 |
Why?
|
Cohort Studies | 6 | 2023 | 41335 | 0.130 |
Why?
|
Male | 27 | 2023 | 359744 | 0.130 |
Why?
|
Blood Cell Count | 1 | 2016 | 397 | 0.130 |
Why?
|
Erythrocyte Deformability | 1 | 2015 | 55 | 0.120 |
Why?
|
Oligonucleotide Array Sequence Analysis | 4 | 2008 | 3775 | 0.120 |
Why?
|
Cytokines | 2 | 2010 | 7343 | 0.120 |
Why?
|
T-Lymphocytes | 2 | 2018 | 10181 | 0.120 |
Why?
|
Blood Viscosity | 1 | 2015 | 124 | 0.120 |
Why?
|
CD4-Positive T-Lymphocytes | 3 | 2019 | 4353 | 0.120 |
Why?
|
Muscles | 1 | 2019 | 1581 | 0.120 |
Why?
|
Frail Elderly | 1 | 2019 | 752 | 0.110 |
Why?
|
Receptors, Androgen | 1 | 2020 | 1077 | 0.110 |
Why?
|
Gene Expression Regulation | 3 | 2017 | 11903 | 0.110 |
Why?
|
CD4 Lymphocyte Count | 5 | 2013 | 2569 | 0.110 |
Why?
|
Epigenesis, Genetic | 2 | 2023 | 3758 | 0.110 |
Why?
|
Cluster Analysis | 2 | 2012 | 2698 | 0.110 |
Why?
|
Receptors, Fc | 1 | 2017 | 534 | 0.110 |
Why?
|
Receptors, HIV | 1 | 2013 | 159 | 0.110 |
Why?
|
Life Expectancy | 2 | 2019 | 1248 | 0.110 |
Why?
|
Promoter Regions, Genetic | 3 | 2000 | 5785 | 0.110 |
Why?
|
Bone Resorption | 1 | 2017 | 720 | 0.110 |
Why?
|
Monocyte-Macrophage Precursor Cells | 1 | 2012 | 5 | 0.110 |
Why?
|
Simian Acquired Immunodeficiency Syndrome | 1 | 2017 | 538 | 0.100 |
Why?
|
Female | 27 | 2023 | 391270 | 0.100 |
Why?
|
Cross-Sectional Studies | 6 | 2019 | 25942 | 0.100 |
Why?
|
Smad7 Protein | 1 | 2012 | 40 | 0.100 |
Why?
|
DNA, Viral | 5 | 2013 | 2194 | 0.100 |
Why?
|
Bayes Theorem | 3 | 2016 | 2326 | 0.100 |
Why?
|
Biopsy | 2 | 2018 | 6771 | 0.100 |
Why?
|
Transcription, Genetic | 5 | 2012 | 7593 | 0.100 |
Why?
|
Simian immunodeficiency virus | 1 | 2017 | 805 | 0.100 |
Why?
|
Core Binding Factor Alpha 1 Subunit | 1 | 2012 | 158 | 0.100 |
Why?
|
Survivors | 1 | 2022 | 2375 | 0.090 |
Why?
|
Fatigue | 1 | 2018 | 1544 | 0.090 |
Why?
|
Caenorhabditis elegans | 2 | 2010 | 1444 | 0.090 |
Why?
|
Myoblasts, Skeletal | 1 | 2010 | 75 | 0.090 |
Why?
|
Health Status | 1 | 2023 | 4081 | 0.090 |
Why?
|
Animals | 12 | 2024 | 167963 | 0.090 |
Why?
|
3T3 Cells | 1 | 2012 | 1085 | 0.090 |
Why?
|
Bone Morphogenetic Protein 2 | 1 | 2012 | 342 | 0.090 |
Why?
|
Enzyme Induction | 1 | 2010 | 452 | 0.090 |
Why?
|
eIF-2 Kinase | 1 | 2010 | 144 | 0.080 |
Why?
|
Cost of Illness | 1 | 2019 | 1940 | 0.080 |
Why?
|
B-Lymphocyte Subsets | 1 | 2010 | 241 | 0.080 |
Why?
|
Muscle Cells | 1 | 2010 | 195 | 0.080 |
Why?
|
Transcription Factors | 4 | 2012 | 12103 | 0.080 |
Why?
|
Models, Biological | 3 | 2010 | 9467 | 0.080 |
Why?
|
Complement C3 | 1 | 2010 | 451 | 0.080 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2013 | 611 | 0.080 |
Why?
|
Lymphocyte Activation | 2 | 2012 | 5496 | 0.080 |
Why?
|
Muscle Development | 1 | 2010 | 259 | 0.080 |
Why?
|
Tacrolimus | 1 | 2012 | 733 | 0.080 |
Why?
|
Immunoglobulin M | 2 | 2010 | 1529 | 0.080 |
Why?
|
Bone Remodeling | 1 | 2012 | 580 | 0.080 |
Why?
|
Adult | 17 | 2023 | 219994 | 0.080 |
Why?
|
Ligands | 2 | 2017 | 3276 | 0.080 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2016 | 1717 | 0.070 |
Why?
|
Drug Synergism | 1 | 2012 | 1754 | 0.070 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2012 | 633 | 0.070 |
Why?
|
Military Personnel | 1 | 2017 | 1244 | 0.070 |
Why?
|
Base Sequence | 8 | 2000 | 12446 | 0.070 |
Why?
|
RNA Stability | 1 | 2010 | 333 | 0.070 |
Why?
|
Anemia, Sickle Cell | 1 | 2016 | 1056 | 0.070 |
Why?
|
Medicare | 2 | 2022 | 6786 | 0.070 |
Why?
|
Signal Transduction | 5 | 2012 | 23376 | 0.070 |
Why?
|
Voluntary Programs | 1 | 2006 | 48 | 0.070 |
Why?
|
Genome, Human | 2 | 2012 | 4417 | 0.070 |
Why?
|
Chemokine CCL8 | 1 | 2006 | 17 | 0.070 |
Why?
|
Monocyte Chemoattractant Proteins | 1 | 2006 | 47 | 0.070 |
Why?
|
Molecular Sequence Data | 8 | 2002 | 17624 | 0.070 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 3804 | 0.070 |
Why?
|
Dietary Supplements | 1 | 2019 | 3392 | 0.070 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2019 | 4550 | 0.070 |
Why?
|
Mothers | 2 | 2006 | 2186 | 0.060 |
Why?
|
Horse Diseases | 1 | 1995 | 54 | 0.060 |
Why?
|
Gene Knockdown Techniques | 1 | 2010 | 1617 | 0.060 |
Why?
|
Pilot Projects | 1 | 2019 | 8555 | 0.060 |
Why?
|
Lipids | 1 | 2016 | 3336 | 0.060 |
Why?
|
AIDS Serodiagnosis | 1 | 2006 | 216 | 0.060 |
Why?
|
Binding Sites | 3 | 2000 | 6048 | 0.060 |
Why?
|
Phagocytosis | 1 | 2010 | 1535 | 0.060 |
Why?
|
tat Gene Products, Human Immunodeficiency Virus | 3 | 2002 | 119 | 0.060 |
Why?
|
Multigene Family | 1 | 2008 | 1077 | 0.060 |
Why?
|
C-Reactive Protein | 1 | 2016 | 3839 | 0.060 |
Why?
|
Sirolimus | 1 | 2012 | 1547 | 0.060 |
Why?
|
Cognition | 2 | 2019 | 6957 | 0.060 |
Why?
|
Diet | 2 | 2020 | 8010 | 0.060 |
Why?
|
RNA-Binding Proteins | 2 | 2010 | 1894 | 0.060 |
Why?
|
Postnatal Care | 1 | 2006 | 260 | 0.060 |
Why?
|
Transcriptional Activation | 2 | 2001 | 1755 | 0.060 |
Why?
|
Peptide Fragments | 1 | 2016 | 5125 | 0.060 |
Why?
|
Reperfusion Injury | 1 | 2010 | 1023 | 0.060 |
Why?
|
Nuclear Proteins | 2 | 2001 | 5791 | 0.060 |
Why?
|
Cell Differentiation | 2 | 2012 | 11481 | 0.060 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2006 | 415 | 0.050 |
Why?
|
Virus Replication | 4 | 2004 | 2432 | 0.050 |
Why?
|
Milk, Human | 1 | 2007 | 483 | 0.050 |
Why?
|
Vitamin D | 1 | 2016 | 3291 | 0.050 |
Why?
|
Mice | 6 | 2015 | 81208 | 0.050 |
Why?
|
RNA, Viral | 4 | 2004 | 2838 | 0.050 |
Why?
|
DNA-Binding Proteins | 2 | 1997 | 9585 | 0.050 |
Why?
|
Toll-Like Receptors | 1 | 2006 | 590 | 0.050 |
Why?
|
Sequence Alignment | 4 | 2002 | 2176 | 0.050 |
Why?
|
Drug Resistance, Viral | 2 | 2004 | 859 | 0.050 |
Why?
|
Blood Glucose | 1 | 2016 | 6381 | 0.050 |
Why?
|
Insulin | 1 | 2016 | 6597 | 0.050 |
Why?
|
Genotype | 4 | 2012 | 12960 | 0.050 |
Why?
|
Mice, Inbred BALB C | 1 | 2010 | 6216 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2010 | 2448 | 0.050 |
Why?
|
Pandemics | 1 | 2021 | 8624 | 0.050 |
Why?
|
Interleukins | 1 | 2006 | 785 | 0.050 |
Why?
|
Jurkat Cells | 2 | 2002 | 736 | 0.050 |
Why?
|
Intestinal Diseases | 1 | 1995 | 506 | 0.050 |
Why?
|
Phylogeny | 5 | 2000 | 2775 | 0.050 |
Why?
|
Boston | 1 | 2013 | 9280 | 0.050 |
Why?
|
Polyesters | 1 | 2022 | 372 | 0.040 |
Why?
|
Body Weight | 3 | 2019 | 4611 | 0.040 |
Why?
|
Sequence Homology, Nucleic Acid | 2 | 1998 | 1055 | 0.040 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 4573 | 0.040 |
Why?
|
Zimbabwe | 1 | 2000 | 135 | 0.040 |
Why?
|
Response Elements | 1 | 2001 | 308 | 0.040 |
Why?
|
Abdomen | 1 | 1995 | 1130 | 0.040 |
Why?
|
Polypharmacy | 1 | 2022 | 307 | 0.040 |
Why?
|
Adolescent | 7 | 2020 | 87810 | 0.040 |
Why?
|
Hypertension | 1 | 2019 | 8594 | 0.040 |
Why?
|
Phosphorylation | 1 | 2010 | 8313 | 0.040 |
Why?
|
Receptors, Interleukin-6 | 1 | 2020 | 226 | 0.040 |
Why?
|
Gene Frequency | 3 | 2012 | 3615 | 0.040 |
Why?
|
Counseling | 1 | 2006 | 1548 | 0.040 |
Why?
|
Vagina | 1 | 2003 | 837 | 0.040 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2023 | 1135 | 0.040 |
Why?
|
Interferon-gamma | 1 | 2006 | 3157 | 0.040 |
Why?
|
Aged, 80 and over | 6 | 2023 | 58995 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2012 | 15789 | 0.040 |
Why?
|
Models, Genetic | 2 | 2012 | 3442 | 0.030 |
Why?
|
Body Weights and Measures | 1 | 2017 | 208 | 0.030 |
Why?
|
Transcription Factor RelA | 1 | 1997 | 251 | 0.030 |
Why?
|
Cell Proliferation | 1 | 2012 | 10446 | 0.030 |
Why?
|
NF-kappa B p50 Subunit | 1 | 1996 | 106 | 0.030 |
Why?
|
Hormones | 1 | 2020 | 867 | 0.030 |
Why?
|
Peptide Chain Initiation, Translational | 1 | 1996 | 100 | 0.030 |
Why?
|
Macrophages | 1 | 2010 | 5745 | 0.030 |
Why?
|
Infant, Newborn | 3 | 2006 | 26181 | 0.030 |
Why?
|
NFATC Transcription Factors | 1 | 1997 | 381 | 0.030 |
Why?
|
Weight Loss | 1 | 2007 | 2686 | 0.030 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2019 | 700 | 0.030 |
Why?
|
Appetite | 1 | 2017 | 247 | 0.030 |
Why?
|
Young Adult | 5 | 2023 | 58741 | 0.030 |
Why?
|
Personality Assessment | 1 | 2017 | 650 | 0.030 |
Why?
|
Odds Ratio | 2 | 2022 | 9716 | 0.030 |
Why?
|
Prospective Studies | 2 | 2018 | 54303 | 0.030 |
Why?
|
Calibration | 1 | 2017 | 816 | 0.030 |
Why?
|
Recombination, Genetic | 1 | 1999 | 1526 | 0.030 |
Why?
|
Stem Cells | 1 | 2007 | 3523 | 0.030 |
Why?
|
Escherichia coli Proteins | 1 | 2001 | 1066 | 0.030 |
Why?
|
DNA | 1 | 2008 | 7233 | 0.030 |
Why?
|
Linkage Disequilibrium | 2 | 2009 | 1996 | 0.030 |
Why?
|
Substance Abuse, Intravenous | 1 | 1998 | 530 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2019 | 15757 | 0.030 |
Why?
|
Orchiectomy | 1 | 2015 | 470 | 0.030 |
Why?
|
Rural Population | 1 | 2003 | 2268 | 0.030 |
Why?
|
Patient Acceptance of Health Care | 1 | 2006 | 3164 | 0.030 |
Why?
|
Receptors, Cell Surface | 1 | 2001 | 2825 | 0.020 |
Why?
|
Menopause | 1 | 2019 | 1640 | 0.020 |
Why?
|
Up-Regulation | 1 | 2020 | 4122 | 0.020 |
Why?
|
Research | 1 | 2019 | 1974 | 0.020 |
Why?
|
Age Distribution | 1 | 2017 | 2893 | 0.020 |
Why?
|
Smad3 Protein | 1 | 2010 | 167 | 0.020 |
Why?
|
Macaca mulatta | 1 | 2017 | 2316 | 0.020 |
Why?
|
HeLa Cells | 1 | 1996 | 3105 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2016 | 2362 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2005 | 18957 | 0.020 |
Why?
|
Virus Internalization | 1 | 2013 | 494 | 0.020 |
Why?
|
Reproducibility of Results | 3 | 2017 | 20080 | 0.020 |
Why?
|
Gene Products, gag | 2 | 2001 | 312 | 0.020 |
Why?
|
Reference Values | 1 | 2016 | 4925 | 0.020 |
Why?
|
Chromosomes, Human, Pair 10 | 1 | 2009 | 276 | 0.020 |
Why?
|
Genetic Variation | 2 | 2001 | 6551 | 0.020 |
Why?
|
United States | 3 | 2022 | 72461 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2022 | 12427 | 0.020 |
Why?
|
Campylobacter jejuni | 1 | 2007 | 25 | 0.020 |
Why?
|
Bacterial Proteins | 1 | 2001 | 3826 | 0.020 |
Why?
|
Infant | 2 | 2007 | 36060 | 0.020 |
Why?
|
Pregnancy | 3 | 2007 | 29749 | 0.020 |
Why?
|
Haemophilus influenzae | 1 | 2007 | 180 | 0.020 |
Why?
|
Maternal-Child Health Centers | 1 | 2006 | 42 | 0.020 |
Why?
|
HIV Seroprevalence | 1 | 2006 | 89 | 0.020 |
Why?
|
Bone Marrow | 1 | 2017 | 2912 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2022 | 80372 | 0.020 |
Why?
|
Family | 1 | 2017 | 3189 | 0.020 |
Why?
|
Erythrocytes | 1 | 2015 | 2415 | 0.020 |
Why?
|
Mortality | 1 | 2017 | 2916 | 0.020 |
Why?
|
Antibody Specificity | 1 | 2007 | 1060 | 0.020 |
Why?
|
Fetal Hemoglobin | 1 | 2008 | 342 | 0.020 |
Why?
|
Age Factors | 2 | 2016 | 18416 | 0.020 |
Why?
|
Marital Status | 1 | 2006 | 433 | 0.020 |
Why?
|
Horses | 1 | 1995 | 298 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2015 | 22023 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 1996 | 4490 | 0.010 |
Why?
|
DNA Primers | 2 | 1999 | 2819 | 0.010 |
Why?
|
Occupations | 1 | 2006 | 515 | 0.010 |
Why?
|
HIV Protease | 1 | 2004 | 97 | 0.010 |
Why?
|
HIV Core Protein p24 | 1 | 2004 | 245 | 0.010 |
Why?
|
Cloning, Molecular | 2 | 2000 | 4169 | 0.010 |
Why?
|
Helicobacter pylori | 1 | 2007 | 377 | 0.010 |
Why?
|
Bone Density | 1 | 2017 | 3534 | 0.010 |
Why?
|
Immunoglobulin A | 1 | 2007 | 979 | 0.010 |
Why?
|
Maternal Age | 1 | 2006 | 807 | 0.010 |
Why?
|
Sutures | 1 | 1995 | 293 | 0.010 |
Why?
|
Postoperative Complications | 1 | 1995 | 15697 | 0.010 |
Why?
|
HIV Enhancer | 1 | 2002 | 3 | 0.010 |
Why?
|
Models, Statistical | 2 | 2012 | 5075 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2013 | 4713 | 0.010 |
Why?
|
Hospitalization | 1 | 2022 | 10790 | 0.010 |
Why?
|
Time Factors | 3 | 2015 | 40165 | 0.010 |
Why?
|
U937 Cells | 1 | 2002 | 262 | 0.010 |
Why?
|
Algorithms | 3 | 2009 | 13981 | 0.010 |
Why?
|
Streptococcus pneumoniae | 1 | 2007 | 732 | 0.010 |
Why?
|
Pattern Recognition, Automated | 1 | 2008 | 994 | 0.010 |
Why?
|
HIV Protease Inhibitors | 1 | 2004 | 432 | 0.010 |
Why?
|
Cyclin T | 1 | 2001 | 19 | 0.010 |
Why?
|
Genetic Markers | 1 | 2008 | 2608 | 0.010 |
Why?
|
Antibodies, Bacterial | 1 | 2007 | 1468 | 0.010 |
Why?
|
Africa, Southern | 1 | 2001 | 59 | 0.010 |
Why?
|
Sleep | 1 | 2017 | 4751 | 0.010 |
Why?
|
Research Design | 1 | 2017 | 6180 | 0.010 |
Why?
|
Chemoreceptor Cells | 1 | 2001 | 89 | 0.010 |
Why?
|
Alleles | 1 | 2012 | 6898 | 0.010 |
Why?
|
Sex Distribution | 1 | 1995 | 2295 | 0.010 |
Why?
|
HIV-2 | 1 | 2001 | 156 | 0.010 |
Why?
|
Polymerase Chain Reaction | 2 | 2000 | 6068 | 0.010 |
Why?
|
Body Mass Index | 1 | 2017 | 12914 | 0.010 |
Why?
|
Health Care Surveys | 1 | 2006 | 2435 | 0.010 |
Why?
|
Breast Feeding | 1 | 2007 | 1355 | 0.010 |
Why?
|
Educational Status | 1 | 2006 | 2515 | 0.010 |
Why?
|
Cyclins | 1 | 2001 | 593 | 0.010 |
Why?
|
Health Services Needs and Demand | 1 | 2006 | 1399 | 0.010 |
Why?
|
Amino Acid Sequence | 2 | 2002 | 13451 | 0.010 |
Why?
|
Consensus Sequence | 1 | 1999 | 365 | 0.010 |
Why?
|
Senegal | 1 | 1999 | 256 | 0.010 |
Why?
|
Disease Progression | 2 | 2010 | 13502 | 0.010 |
Why?
|
Cytopathogenic Effect, Viral | 1 | 1998 | 151 | 0.010 |
Why?
|
Ukraine | 1 | 1998 | 137 | 0.010 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2001 | 503 | 0.010 |
Why?
|
Gene Products, env | 1 | 1999 | 250 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2006 | 6238 | 0.010 |
Why?
|
Treatment Failure | 1 | 2004 | 2648 | 0.010 |
Why?
|
Giant Cells | 1 | 1998 | 185 | 0.010 |
Why?
|
Genes, Viral | 1 | 1998 | 650 | 0.010 |
Why?
|
North America | 1 | 2001 | 1284 | 0.010 |
Why?
|
Oligonucleotides | 1 | 2000 | 588 | 0.010 |
Why?
|
Molecular Epidemiology | 1 | 1998 | 469 | 0.010 |
Why?
|
DNA Transposable Elements | 1 | 2000 | 756 | 0.010 |
Why?
|
Plasmids | 1 | 2001 | 2275 | 0.010 |
Why?
|
Computational Biology | 1 | 2008 | 3505 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 2007 | 4541 | 0.010 |
Why?
|
Mutation, Missense | 1 | 2004 | 2566 | 0.010 |
Why?
|
Computer Simulation | 1 | 2008 | 6218 | 0.010 |
Why?
|
Tanzania | 1 | 1999 | 1383 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 1998 | 2753 | 0.010 |
Why?
|
Europe | 1 | 2001 | 3441 | 0.010 |
Why?
|
HIV Seropositivity | 1 | 1999 | 955 | 0.010 |
Why?
|
India | 1 | 2000 | 2336 | 0.010 |
Why?
|
Transfection | 1 | 2001 | 5781 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2006 | 7806 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2008 | 14660 | 0.010 |
Why?
|
Gene Deletion | 1 | 2000 | 2668 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2006 | 3986 | 0.010 |
Why?
|
Logistic Models | 1 | 2006 | 13314 | 0.010 |
Why?
|
Drosophila Proteins | 1 | 2001 | 1699 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2010 | 65017 | 0.010 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1999 | 2197 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2012 | 17790 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2007 | 22053 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2004 | 14495 | 0.000 |
Why?
|
Pregnancy Complications, Infectious | 1 | 1999 | 2125 | 0.000 |
Why?
|
Survival Rate | 1 | 1999 | 12808 | 0.000 |
Why?
|
Child, Preschool | 1 | 2007 | 42063 | 0.000 |
Why?
|
Risk Factors | 1 | 2007 | 74359 | 0.000 |
Why?
|
Phenotype | 1 | 1998 | 16546 | 0.000 |
Why?
|